Sfoglia per AUTORE
TEKTONIDOU MG
Collezione ASL Città di Torino

  

Items : 6

2025
ASL Città di Torino

Ahmadzadeh Y; Magder LS; de Andrade DCO; Paredes-Ruiz D; Tektonidou MG; Pengo V; Sciascia S; Andreoli L; Signorelli F; Fortin PR; Efthymiou M; Belmont HM; Barilaro G; Clarke AE; Atsumi T; López-Pedrera C; Knight JS; Branch DW; Willis R; Kello N; Zhang Z; Almaraz ER; Artim-Esen B; Pardos-Gea J; Pons-Estel G; Pazzola G; Shi H; Duarte-García A; Thaler J; et alii...

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Feb 6;63(SI):SI24-SI36. doi: 10.1093/rheumatology/kead571.
2024
ASL Città di Torino

Gaspar P; Sciascia S; Tektonidou MG;

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis. in Arthritis care & research / Arthritis Care Res (Hoboken). 2024 Dec;76(12):1617-1625. doi: 10.1002/acr.25415. Epub 2024 Sep 30.
2024
ASL Città di Torino

Barbhaiya M; Zuily S; Amigo MC; Andrade D; Avcin T; Bertolaccini ML; Branch DW; Costedoat-Chalumeau N; Crowther M; Ramires de Jesus G; Devreese KMJ; Frances C; Garcia D; Gómez-Puerta JA; Guillemin F; Levine SR; Levy RA; Lockshin MD; Ortel TL; Petri M; Sanna G; Sciascia S; Seshan SV; Tektonidou MG; Wahl D; Willis R; Yelnik C; Hendry A; Naden R; et alii...

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28.
2023
ASL Città di Torino

Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesus G; Delluc A; Desai S; De Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-Garcia A; Frances C; et alii...

2023 ACR/EULAR antiphospholipid syndrome classification criteria. in Annals of the rheumatic diseases / Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28.
2023
ASL Città di Torino

Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesús G; Delluc A; Desai S; Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-García A; Frances C; et alii...

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2.
2022
ASL Città di Torino

Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG;